Metagenomi (MGX)
1.15
-0.01 (0.86%)
Upcoming Events
Latest Headlines
Form 4 Metagenomi Therapeutics, For: Sep 09 Filed by: Reid Laurence
September 11, 2026 7:52 PM - SEC Filing
Form SCHEDULE 13G Metagenomi Therapeutics, Filed by: Thomas Brian C.
September 10, 2026 4:05 PM - SEC Filing
Form 4 Metagenomi Therapeutics, For: Sep 08 Filed by: Wein Matthew
September 10, 2026 3:47 PM - SEC Filing
Form 4 Metagenomi Therapeutics, For: Sep 08 Filed by: Irish Jian
September 10, 2026 3:40 PM - SEC Filing
Form 4 Metagenomi Therapeutics, For: Sep 08 Filed by: Wapnick Pamela
September 10, 2026 3:35 PM - SEC Filing
Metagenomi Therapeutics, Inc. to Present at the Wells Fargo 21st Annual Healthcare Conference
September 1, 2026 8:00 AM - StreetInsider
Metagenomi Inc (MGX) PT Lowered to $7 at Wells Fargo
August 11, 2026 6:56 AM - StreetInsider
Metagenomi, Inc. (MGX) Tops Q2 EPS by 5c
August 10, 2026 6:23 PM - StreetInsider
Form 10-Q Metagenomi Therapeutics, For: Jun 30
August 10, 2026 4:13 PM - SEC Filing
Form 8-K Metagenomi Therapeutics, For: Aug 10
August 10, 2026 4:11 PM - SEC Filing
Metagenomi Therapeutics Reports Business Updates and Second Quarter 2026 Financial Results
August 10, 2026 4:05 PM - StreetInsider
Prolynx names CFO and CSO to advance obesity drug portfolio
July 15, 2026 8:01 AM - StreetInsider
Prolynx Names Simon Harnest as Chief Financial Officer and Amer Mirza, PhD, as Chief Scientific Officer as It Advances Multi-Program Obesity and Metabolic Disease Portfolio
July 15, 2026 8:00 AM - Globe NewsWire
Chardan Starts Metagenomi Inc (MGX) at Buy
July 7, 2026 6:37 AM - StreetInsider
Full Article List
